Literature DB >> 26658357

Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.

M Sharifi1, R Salehi1.   

Abstract

MicroRNAs (miRNAs) are non-coding RNAs involved in post-transcriptional regulation of gene expression. In many cancers, up- or downregulation of different miRNAs is reported. In acute myeloid leukemia, upregulation of miR-92a-3p was reported in human in vitro studies. We performed blockage of miR-29a-3p in human acute megakaryoblastic leukemia cell line (M-07e) by using locked nucleic acid (LNA) and cell proliferation; apoptosis and necrosis were assessed. At different time points after LNA-anti-miR92a-3p transfection, miR-92a-3p quantitation was assessed by qRT-real-time PCR, MTT assay and annexin/propidium iodide staining were performed. The data were processed using the ANOVA test. At all three time points, the expression of miR-92a-3p was lower in the LNA-anti-miR group compared with the control groups. Cell viability between LNA-Anti-miR and the control group was statistically significant. Blockage of miR-92a-3p was associated with increment of the ratio of apoptotic cells in the LNA-anti-miR group was higher than the other group. The ratio of necrotic cells in the LNA-antimiR group was higher than the other groups. These assessments indicate that miR-92a-3p blockage can decrease the viability of M-07e cells, which is mainly due to induction of apoptosis and necrosis. Our findings could open up a path to a miRNA based therapeutic approach for treatment of acute megakaryoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26658357     DOI: 10.1038/cgt.2015.63

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  34 in total

1.  LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

Authors:  Ulf Andersson Ørom; Sakari Kauppinen; Anders H Lund
Journal:  Gene       Date:  2006-02-24       Impact factor: 3.688

2.  Acute megakaryoblastic leukemia.

Authors:  Armin Rashidi; Stephen I Fisher
Journal:  Blood       Date:  2013-10-10       Impact factor: 22.113

Review 3.  Regulation of microRNA biogenesis.

Authors:  Minju Ha; V Narry Kim
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07-16       Impact factor: 94.444

4.  Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.

Authors:  Hakeemah Al-Nakhle; Philip A Burns; Michele Cummings; Andrew M Hanby; Thomas A Hughes; Sampoorna Satheesha; Abeer M Shaaban; Laura Smith; Valerie Speirs
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 5.  miR-92a family and their target genes in tumorigenesis and metastasis.

Authors:  Molin Li; Xingfang Guan; Yuqiang Sun; Jun Mi; Xiaohong Shu; Fang Liu; Chuangang Li
Journal:  Exp Cell Res       Date:  2014-01-04       Impact factor: 3.905

6.  Acute myeloblastic leukemia.

Authors:  Carmen Avellaneda Molina; Maria José Requena Rodríguez; Nieves Somolinos de Marcos; Patricia Font
Journal:  Adv Ther       Date:  2011-03-09       Impact factor: 3.845

7.  The microRNA miR-92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms.

Authors:  Isabella Manni; Simona Artuso; Silvia Careccia; Maria Giulia Rizzo; Renato Baserga; Giulia Piaggio; Ada Sacchi
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

Review 8.  MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.

Authors:  Ugo Testa; Elvira Pelosi
Journal:  Leuk Lymphoma       Date:  2015-01-21

9.  Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.

Authors:  Junko H Ohyashiki; Tomohiro Umezu; Chiaki Kobayashi; Ryoko S Hamamura; Masami Tanaka; Masahiko Kuroda; Kazuma Ohyashiki
Journal:  BMC Res Notes       Date:  2010-12-24

10.  MicroRNA Gene Networks in Oncogenesis.

Authors:  Alexandra Drakaki; Dimitrios Iliopoulos
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more
  16 in total

1.  Suppressive role of microRNA-29 in hepatocellular carcinoma via targeting IGF2BP1.

Authors:  Jianyi Yang; Xuejun Gong; Jing Yang; Linghua Ouyang; Rou Xiao; Xing You; Yanlan Ouyang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  MicroRNA-92a promotes cell viability and invasion in cervical cancer via directly targeting Dickkopf-related protein 3.

Authors:  Shengtian Luo; Na Li; Shaohua Yu; Lichun Chen; Chunying Liu; Jiawei Rong
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

3.  Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.

Authors:  Alexander V Lavrov; Ekaterina Yu Chelysheva; Elmira P Adilgereeva; Oleg A Shukhov; Svetlana A Smirnikhina; Konstantin S Kochergin-Nikitsky; Valentina D Yakushina; Grigory A Tsaur; Sergey V Mordanov; Anna G Turkina; Sergey I Kutsev
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

4.  Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage.

Authors:  Mahdi Fasihi-Ramandi; Abbas Moridnia; Ali Najafi; Mohammadreza Sharifi
Journal:  Indian J Hematol Blood Transfus       Date:  2017-03-29       Impact factor: 0.900

5.  Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation.

Authors:  S Ahmadi; M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

6.  Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.

Authors:  R Nedaeinia; M Sharifi; A Avan; M Kazemi; L Rafiee; M Ghayour-Mobarhan; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-07-01       Impact factor: 5.987

Review 7.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

8.  Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Yilun Sun; Peter G Hawkins; Nan Bi; Robert T Dess; Muneesh Tewari; Jason W D Hearn; James A Hayman; Gregory P Kalemkerian; Theodore S Lawrence; Randall K Ten Haken; Martha M Matuszak; Feng-Ming Kong; Shruti Jolly; Matthew J Schipper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-04       Impact factor: 7.038

Review 9.  The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Garima Sharma; Bimal Kumar Sarkar; Sang-Soo Lee
Journal:  Oncotarget       Date:  2018-01-23

10.  Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.

Authors:  Medi Kori; Kazim Yalcin Arga
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.